<DOC>
	<DOCNO>NCT02361619</DOCNO>
	<brief_summary>Four period oral dose follow overnight fasting ( 1. know metabolic probe drug cocktail consist caffeine , diclofenac , esomeprazole , metoprolol , midazolam ; 2. dabigatran + cocktail ; 3. dabigatran alone ; 4. clarithromycin 3 day + cocktail + dabigatran ) . Blood sample collect pharmacokinetics 24 h. Washout period . Adverse event , haematology clinical chemistry record .</brief_summary>
	<brief_title>Dabigatran Interaction Probe Drug Cocktail</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy Weight least 50 kg body mass index 19 30 kg m2 Normal clinical laboratory profile No childbearing potential use adequate contraceptive measure Blood loss &gt; 300 ml within 2 month prior first dose day Pregnancy , breastfeed Allergy hypersensitivity caffeine , diclofenac , esomeprazole , metoprolol , midazolam , dabigatran clarithromycin excipients pharmaceutical product Infection HIV , HBV HCV Participation precede 3 month concomitantly clinical drug study Suspected current drug alcohol abuse History drug alcohol abuse . Concomitant medication exception hormonal contraception . Positive result urine test drug abuse . Nicotine consumption equivalent &gt; 5 cigarette per day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>